계혈등복합방(GC)의 TNF-α와 IL-1β로 유도된 인간 섬유아세포양 활막 세포 활성화 억제 작용
Inhibitory Effects of GC, an Extract from Herbs, on TNF-α/IL-1β -induced Activation of Human Fibroblast-like Sinoviocytes
0
조회
0
다운로드
1
인용
0
참고문헌
초록
Abstract
Based on traditional medicine theories, GC, an extract from 5 herbs, has been formulated and prescribed for the treatment of human rheumatoid arthritis(hRA) for many years. The present studies was done to investigate whether GC has inhibitory effects on activation of fibroblast-like sinoviocytes isolated from a RA patient. In tumor necrosis factor-a(TNF-α)/ interleukin-1β(IL-1β) treated human sinoviocytes, the mRNA expression of molecular indicators related to pathologic changes of the sinoviocytes were examined using quantitative real-time PCR. The treatment of GC(10 ㎍/ml) significantly suppressed the expression of proinflammatory cytokines and chemokines such as TNF-a, IL-6 and IL-8 compared with the control, but not IL-1b. The mRNA level of intracellular adhesion molecule-1(ICAM-1) which is known to increase in the activated sinoviocytes of RA patients, was slightly decreased by GC. The expression of NOS-II was considerably reduced, which was accompanied by a decrease in the production of nitric oxide(NO). Furthermore, GC dramatically raised the mRNA levels of tissue inhibitors of matrix metalloproteinase-1(TIMP-1), while those of matrix metalloproteinase-3 were significantly lowered. Taken together, these data suggested that GC might suppress the activation of sinoviocytes in hRA.
참고문헌 (21)
- Firestein, "Evolving concepts of rheumatoid arthritis", 423, pp.356~361 (2003)
- Burmester, "mastermind or workhorse in arthritis", 40, pp.5~18 (2001)
- Chu, "Localization of tumor necrosis factor alpha in synovial tissue and at the cartilage-pannus junction in patients with rheumatoid arthritis", pp.1125~1132 (1991)
- Badolato, "Role of cytokines and chemokines in the progression of rheumatoid arthritis", 26, pp.526~538 (1996)
- Yoshihara, "Matrix metalloproteinase and tissue inhibitors of metalloproteinase in synovial fluids from patients with rheumatoid arthritis or osteoarthritis", 59, pp.455~461 (2000)
- Jackson, "Rheumatoid synovial endothelial cells secrete decreased levels of tissue inhibitor of MMP", 57, pp.157~161 (1998)
- 서혜경, "관절염활막세포에 대한 계혈등의 면역효과" (2003)
- 이진훈, "계혈등의 항염활성효과" (1999)
- 김병수, "玄胡索.赤芍藥.紅花 混合藥鍼液이 關節炎 白鼠의 炎症과 肝에 미치는 影響" (2004)
- 조영주, "희첨이 炎症性 싸이토카인 및 류마티스양 關節炎에 미치는 影響" (2003)
- "Optimization of the sulforhodamin B", 208, pp.151~158 (1997)
- Rho, "Effects of TGF-b GM-CSF and PDGF on proliferation and expression of cytokines and metalloproteinase genes in rheumatoid synovial cells", 20, pp.119~127 (1998)
- Tanaka, "The role of chemokine and adhesion molecules in the pathogenesis of rheumatoid arthritis", 37, pp.477~485 (2001)
- Guerra, "A histochemical study of the rheumatoid synovium focus on nitric oxide", 27, pp.1121~1127 (2000)
- Studer, "Nitric oxide in osteoarthritis 7", 7, pp.377~3779 (1999)
- 路志正, "實用中醫風濕病學" (1996), 인민위생출판사
- A, "Pannus invasion and cartilage degradation in rheumatoid arthritis Involvement of MMP-3 and interleukin-1b", 23, pp.644~650 (2005)
- North, "hand and foot bone mineral content and the development of joint erosions in RA Ann", pp.543~546 (1994)
- Okamoto, "The synovial expression and serum levels of IL-6 and oncostatin M in rheumatoid arthritis", 40, pp.1096~2105 (1997)
- Sato, "IL-6 and IL-6 receptors in the synovial fluids from rheumatoid arthritis patients are responsible for osteolike cell formation J", 11, pp.88~95 (1996)
- A, "Synovial MMP-3 and TIMP-1 levels and their correlation with cytokine expression in canine rheumatoid arthritis", 91, pp.199~204 (2003)
